PMV Pharmaceuticals Inc. (PMVP) Stock: Evaluating the Market Performance

Analysts have varying opinions on the stock, with 7 analysts rating it as a “buy,” 0 as “overweight,” 0 as “hold,” and 0 as “sell.”

The average price recommended by analysts for PMV Pharmaceuticals Inc. (PMVP) is $21.50, which is $15.54 above the current market price. The public float for PMVP is 44.72M and currently, short sellers hold a 14.68% of that float. On June 19, 2023, PMVP’s average trading volume was 474.34K shares.

Top 5 AI Stocks to Buy for 2023

The artificial intelligence (AI) revolution is already here. And it’s about to change everything we know about everything.
According to Grand View Research, the global AI boom could grow from about $137 billion in 2022 to more than $1.81 trillion by 2030. And investors like you always want to get in on the hottest stocks of tomorrow. Here are five of the best ways to profit from the AI boom.

Click Here to Download the FREE Report.


PMVP) stock’s latest price update

PMV Pharmaceuticals Inc. (NASDAQ: PMVP)’s stock price has dropped by -4.94 in relation to previous closing price of 6.27. Nevertheless, the company has seen a gain of 8.96% in its stock price over the last five trading days.

PMVP’s Market Performance

PMV Pharmaceuticals Inc. (PMVP) has seen a 8.96% rise in stock performance for the week, with a 5.49% gain in the past month and a 9.36% surge in the past quarter. The volatility ratio for the week is 7.93%, and the volatility levels for the past 30 days are at 7.20% for PMVP. The simple moving average for the past 20 days is 4.91% for PMVP’s stock, with a -28.58% simple moving average for the past 200 days.

Analysts’ Opinion of PMVP

Many brokerage firms have already submitted their reports for PMVP stocks, with Oppenheimer repeating the rating for PMVP by listing it as a “Outperform.” The predicted price for PMVP in the upcoming period, according to Oppenheimer is $30 based on the research report published on March 02nd of the previous year 2022.

PMVP Trading at 16.30% from the 50-Day Moving Average

After a stumble in the market that brought PMVP to its low price for the period of the last 52 weeks, the company was unable to rebound, for now settling with -66.47% of loss for the given period.

Volatility was left at 7.20%, however, over the last 30 days, the volatility rate increased by 7.93%, as shares surge +5.30% for the moving average over the last 20 days. Over the last 50 days, in opposition, the stock is trading +38.93% upper at present.

During the last 5 trading sessions, PMVP rose by +8.96%, which changed the moving average for the period of 200-days by -56.56% in comparison to the 20-day moving average, which settled at $5.70. In addition, PMV Pharmaceuticals Inc. saw -31.49% in overturn over a single year, with a tendency to cut further losses.

Stock Fundamentals for PMVP

The total capital return value is set at -26.58, while invested capital returns managed to touch -25.33. Equity return is now at value -29.20, with -26.70 for asset returns.

Based on PMV Pharmaceuticals Inc. (PMVP), the company’s capital structure generated 5.68 points at debt to equity in total, while total debt to capital is 5.38. Total debt to assets is 5.17, with long-term debt to equity ratio resting at 5.47. Finally, the long-term debt to capital ratio is 5.17.

The liquidity ratio also appears to be rather interesting for investors as it stands at 22.80.


To wrap up, the performance of PMV Pharmaceuticals Inc. (PMVP) has been mixed in recent times. The stock has received a bullish of “buy” and “hold” ratings from analysts. It’s important to note that the stock is currently trading at a significant distance from its 50-day moving average and its 52-week high.